The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways.
about
Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomyThe TCL1A oncoprotein interacts directly with the NF-kappaB inhibitor IkappaB.Protein kinase C-theta is required for efficient positive selection.Protein kinase C signalling in leukemia.High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemiaSotrastaurin, a protein kinase C inhibitor, ameliorates ischemia and reperfusion injury in rat orthotopic liver transplantation.
P2860
The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCtheta and ERK pathways.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The TCL1 oncoprotein inhibits ...... ing PKCtheta and ERK pathways.
@en
type
label
The TCL1 oncoprotein inhibits ...... ing PKCtheta and ERK pathways.
@en
prefLabel
The TCL1 oncoprotein inhibits ...... ing PKCtheta and ERK pathways.
@en
P2093
P1433
P1476
The TCL1 oncoprotein inhibits ...... ring PKCtheta and ERK pathways
@en
P2093
Emilie Le Toriellec
Gilles Despouy
Marjorie Joiner
Robert Weil
P304
P356
10.1182/BLOOD-2006-11-059501
P407
P577
2007-09-10T00:00:00Z